When pollen grains, dust mite particles, or fungal enzymes drift into the lungs of a susceptible person, they land on the delicate epithelial cells lining the airways and trigger a cascade that can spiral into asthma. For decades, immunologists have known that these allergens prompt those cells to release an alarm signal called interleukin-33, which marshals an army of type 2 innate lymphoid cells, eosinophils, and mucus-producing machinery. But the very first biochemical switch that translates an encounter with an innocuous protein into a full-blown allergic attack has remained frustratingly obscure. Now a team of researchers in China has discovered that the switch is made of iron. In a study published on 26 June 2026 in Cell, the scientists reveal that environmental allergens commandeer the body’s own labile iron pool to shatter a pore-forming protein named gasdermin D inside airway epithelial cells, unleashing IL-33 through a radically unconventional cleavage mechanism.
The work, led by Sun Bing at the Center for Excellence in Molecular Cell Science of the Chinese Academy of Sciences and Liu Xing at the Shanghai Institute of Materia Medica, began with a puzzling observation. Previous studies had established that gasdermin D participates in IL-33 release, but the protein was thought to be activated almost exclusively by inflammatory caspases that slice it into a membrane-perforating fragment. Allergens, however, did not seem to engage those canonical enzymes. Using mouse models challenged with papain, a plant protease frequently employed to mimic environmental allergens, or with house dust mite extracts, the researchers documented a rapid spike in free iron within lung tissue that paralleled the surge of IL-33 secretion. When they treated the animals with the iron-chelating drug deferiprone, gasdermin D cleavage and IL-33 release were powerfully suppressed; conversely, supplementing iron drove both processes to excess.
Searching for the entry point that couples allergen detection to iron mobilization, the team identified the cell-surface receptor PAR1. Papain directly cleaves this receptor, and the proteolytic nick sets off a cascade of events inside the cell that activates NCOA4, a cargo receptor that selects ferritin—the cell’s iron-storage protein—for autophagic destruction. This selective ferritinophagy liberates a burst of labile iron. That iron is not left to drift randomly; instead, the iron chaperone PCBP2 shepherds it directly to gasdermin D, docking at two specific amino acid residues, E309 and Q312. When the researchers mutated those sites, gasdermin D could no longer bind iron, and neither cleavage nor IL-33 release occurred.
What happens at the gasdermin D molecule itself upends textbook descriptions of how the protein can be activated. The iron delivered by PCBP2 does not wait for a protease. In the oxygen-rich environment of the cell, ferrous iron catalyzes a local Fenton reaction, generating highly reactive hydroxyl radicals. These short-range oxidants attack the gasdermin D polypeptide backbone, snapping it in a manner that yields the active N-terminal fragment capable of punching holes in the plasma membrane. It is, the authors emphasize, an oxidative cleavage process entirely independent of the inflammasome-associated caspases that are normally thought of as gasdermin D’s sole executioners.
The physiological consequences of this iron–gasdermin D–IL-33 axis proved stark in living animals. Prophylactic administration of the iron chelator dramatically reduced eosinophil infiltration into the lungs, lowered levels of the type 2 cytokines IL-5 and IL-13, and curbed the overproduction of airway mucus. Iron supplementation, by contrast, worsened all of these inflammatory hallmarks. Critically, in mice genetically engineered to lack gasdermin D, extra iron failed to amplify the allergic response, confirming that the pro-inflammatory power of iron is channeled entirely through this pore-forming protein.
The findings reframe allergic airway inflammation as, in significant part, a disorder of local iron dysregulation. Each step of the newly charted pathway—allergen-mediated PAR1 cleavage, NCOA4-driven ferritinophagy, PCBP2-mediated iron delivery, and the hydroxyl-radical scission of gasdermin D—constitutes a potential therapeutic node. Drugs that modulate any of these targets might short-circuit the upstream alarmin release before the adaptive immune system ever becomes involved. The study also expands the immunological repertoire of gasdermin D, showing that the protein can act as a direct sensor of iron-catalyzed oxidative stress, a function that could have implications beyond allergy, in any pathology where tissue iron accumulates.
The research arrives at a time when the intersection of metals and immunity is drawing intense interest. Trace elements such as zinc and manganese have already been shown to influence antimicrobial defenses, but a clear picture of how iron governs sterile type 2 inflammation has been missing. By unveiling a mechanism in which atmospheric proteins pry open a receptor, liberate intracellular iron, and trigger a radical-driven protein cleavage to sound the alarm, Sun, Liu and their colleagues have delivered a conceptual leap. The work suggests that inhaled allergens are not merely passive antigens but active saboteurs that exploit the host’s own iron chemistry to ignite an inflammatory fire.
Subject of Research: Iron-dependent activation of gasdermin D in allergic airway inflammation
Article Title: Iron drives protease-independent cleavage of gasdermin D in allergic airway diseases
News Publication Date: 26-Jun-2026
Web References: 10.1016/j.cell.2026.06.004
References: Sun B et al. Iron drives protease-independent cleavage of gasdermin D in allergic airway diseases. Cell, 2026. DOI: 10.1016/j.cell.2026.06.004
Image Credits:
Keywords: allergic inflammation, asthma, iron, gasdermin D, IL-33, ferroptosis, hydroxyl radical, PAR1, ferritinophagy, PCBP2
